1. The mortality risk associated with higher hemoglobin: is the therapy to blame? 
Mitchell H. Rosner, W. Kline Bolton 
Kidney International 
Volume 74, Issue 6, Pages (September 2008)
DOI: /ki
Copyright © 2008 International Society of Nephrology Terms and Conditions

2. Figure 1
The interplay between factors potentially associated with the increased risk of mortality in CKD/ESRD patients targeted to higher hemoglobin levels. CKD, chronic kidney disease; ESA, erythropoietin-stimulating agent; ESRD, end-stage renal disease.
Kidney International  , DOI: ( /ki )
Copyright © 2008 International Society of Nephrology Terms and Conditions